Share Deep Breaths: Updates from CHEST
Share to email
Share to Facebook
Share to X
By ReachMD
The podcast currently has 76 episodes available.
This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.
When it comes to managing acute asthma symptoms and reducing risk for patients, our focus is now on relieving bronchoconstriction and inflammation. Given this fundamental change, it’s important to ensure that our patients understand this shift. Find out how taking a shared decision-making approach can help patients embrace this change in addition to improving their adherence and outcomes with Drs. Demondes Haynes, Njira Lugogo, and Neil Skolnik.
This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.
Expert opinions from NAEPP and GINA recommend treating both symptoms and inflammation in asthma patients concomitantly. Joining Dr. Demondes Haynes to talk about these updates and therapies for asthma like short-acting beta agonists and inhaled corticosteroids are Drs. Njira Lugogo and Neil Skolnik.
This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.
This non-CME education is brought to you by CHEST and is sponsored by AstraZeneca.
The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes
The goal of this activity is to use case-based learning to highlight the importance of targeting TSLP in the three types of severe asthma to raise awareness about optimal
available treatments and best-practices for designing treatment plans to ultimately improve patient outcomes.
It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.
This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.
Respiratory syncytial virus (RSV) is most commonly recognized for the significant disease it causes in infants and young children. However, over time its prevalence in adults has increased. Tune in to learn more with Dr. Ryan Maves as he speaks with Dr. Megan Conroy, Assistant Professor of Medicine at the Ohio State University in Columbus.
This program is produced in partnership with the American College of CHEST Physicians and is supported by an educational grant from GSK.
It’s estimated that respiratory syncytial virus (RSV) is responsible for up to 30 percent of viral respiratory infections in the stem cell transplant population. So how can we help RSV patients achieve their best outcomes? Learn more with Dr. Ryan Maves as he speaks with Dr. Kelly Pennington, Assistant Professor of Medicine at the Mayo Clinic in Rochester, Minnesota.
Bronchiectasis is a complex syndrome that can lead to an interconnected cascade of airway dysfunction and inflammation. How has our understanding of this syndrome evolved with Cole’s vicious cycle hypothesis? Dr. Ashwin Basavaraj and Dr. Christopher Lippincott take a closer look at this hypothesis and the clinical mechanisms behind bronchiectasis.
This program is produced in partnership with the American College of CHEST Physicians, and is sponsored by Insmed Incorporated.
The podcast currently has 76 episodes available.
26 Listeners
3,270 Listeners